| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/20/2002 | WO2002048379A1 Expression vector for animal cell containing nuclear matrix attachment region fo interferon beta |
| 06/20/2002 | WO2002048378A2 Enhancement of freezing tolerance in transgenic plants |
| 06/20/2002 | WO2002048376A2 Bacterial host strains |
| 06/20/2002 | WO2002048375A2 Purified active hcv ns2/3 protease |
| 06/20/2002 | WO2002048370A2 Compositions and methods relating to colon specific genes and proteins |
| 06/20/2002 | WO2002048369A2 Polynucleotide encoding a human potassium channel beta-subunit, k+mbeta1 |
| 06/20/2002 | WO2002048368A2 Proteins associated with cell growth, differentiation, and death |
| 06/20/2002 | WO2002048367A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/20/2002 | WO2002048366A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/20/2002 | WO2002048365A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/20/2002 | WO2002048364A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/20/2002 | WO2002048363A2 Human transporter proteins, nucleic acid molecules encoding them, and uses thereof |
| 06/20/2002 | WO2002048362A2 Embryogenesis associated proteins |
| 06/20/2002 | WO2002048361A2 Novel secreted proteins and their uses |
| 06/20/2002 | WO2002048360A1 Estrogen receptor genes and utilization thereof |
| 06/20/2002 | WO2002048359A1 Magnetic particle membrane-specific protein |
| 06/20/2002 | WO2002048358A2 Regulation of human chemokine-like receptor |
| 06/20/2002 | WO2002048357A1 A novel polypeptide, a human c0p9 compound subunit 37.62 and the polynucleotide encoding the polypeptide |
| 06/20/2002 | WO2002048356A1 A novel polypeptide, a human cytochrome constitutive protein 45 and the polynucleotide encoding the polypeptide |
| 06/20/2002 | WO2002048355A1 A novel polypeptide, a human garp protein 12.98 and the polynucleotide encoding the polypeptide |
| 06/20/2002 | WO2002048354A1 Tumour suppressor gene identified on chromosome 18 |
| 06/20/2002 | WO2002048353A2 Dna-sequences, which code for an apoptosis signal transduction protein |
| 06/20/2002 | WO2002048349A1 Polypeptide capable of binding to heparin |
| 06/20/2002 | WO2002048348A1 Novel gene existing in human leukocyte antigen domain |
| 06/20/2002 | WO2002048346A2 Transgenic mice containing bsmap gene disruptions |
| 06/20/2002 | WO2002048345A2 Transgenic mice containing glutamate receptor (grik5) gene disruptions |
| 06/20/2002 | WO2002048343A2 Transgenic mice containing adrenocorticotropin hormone receptor gene disruptions |
| 06/20/2002 | WO2002048342A2 Knockout mice for trp6 gene |
| 06/20/2002 | WO2002048341A2 Knockout mice for a2d2 calcium ion channel subunit proteins |
| 06/20/2002 | WO2002048339A2 Transgenic mice containing kir5.1 inwardly rectifying potassium channel gene disruptions |
| 06/20/2002 | WO2002048337A2 Secreted human proteins |
| 06/20/2002 | WO2002048335A2 Metal resistant plants and use for phytoremediation |
| 06/20/2002 | WO2002048313A2 Senescence-associated plant promotors |
| 06/20/2002 | WO2002048312A2 Backbone cyclized inhibitors of heat shock proteins |
| 06/20/2002 | WO2002048310A2 Methods and compositions for diagnosing and treating rheumatoid arthritis |
| 06/20/2002 | WO2002048194A1 Fusion protein having the enhanced in vivo activity of erythropoietin |
| 06/20/2002 | WO2002048192A2 Amidated glucagon-like peptide-1 |
| 06/20/2002 | WO2002048191A2 Inhibitory agents derived from specific growth factors |
| 06/20/2002 | WO2002048190A1 Use of l-carnitine as stabilizing agent of proteins |
| 06/20/2002 | WO2002048189A2 Combinatorial libraries of proteins having the scaffold structure of c-type lectin-like domains |
| 06/20/2002 | WO2002048186A1 A novel polypeptide-homo insulinoid growth factor conjugated protein 10.45 and polynucleotide encoding said polypeptide |
| 06/20/2002 | WO2002048185A2 Method for identifying secreted chlamydia polypeptides by using a type iii secretion system of a gram-negative |
| 06/20/2002 | WO2002048184A2 Glycoprotein peptide of the human herpesvirus-7 for use in particular in an elisa serologic test |
| 06/20/2002 | WO2002048183A2 Compositions of peptide crystals |
| 06/20/2002 | WO2002048182A2 Interferon-alpha induced gene |
| 06/20/2002 | WO2002048181A1 Antibodies, peptides, analogs and uses thereof |
| 06/20/2002 | WO2002048180A2 Peptides and/or proteins and use thereof for the production of a therapeutic and/or prophylactic medicament |
| 06/20/2002 | WO2002048176A1 Method of preparing alpha-1 proteinase inhibitor |
| 06/20/2002 | WO2002048175A2 Mhc class i associated peptides for prevention and treatment of tuberculosis |
| 06/20/2002 | WO2002048174A2 Dimeric fluorescent polypeptides |
| 06/20/2002 | WO2002048173A2 Expression of a cadherin-like protein in benign prostatic hyperplasia |
| 06/20/2002 | WO2002048172A2 Diaryl peptides as ns3-serine protease inhibitors of hepatits c virus |
| 06/20/2002 | WO2002047730A2 Intracellular delivery of charged therapeutic moieties to nerve cells by means of targeting proteins |
| 06/20/2002 | WO2002047727A1 Therapeutic agent comprising a b-subunit of a protein toxin |
| 06/20/2002 | WO2002047720A2 Treatment and prevention of ebv infection and ebv-associated disorders |
| 06/20/2002 | WO2002047719A2 Survical promoting ncam binding and ncam ligand biding compounds |
| 06/20/2002 | WO2002047718A2 Methods and compositions for vaccination comprising nucleic acid ad/or polypeptide sequences of $i(chlamydia) |
| 06/20/2002 | WO2002047716A2 Chronic treatment regimen using glucagon-like insulinotropic peptides |
| 06/20/2002 | WO2002047715A2 Compositions of peptide crystals |
| 06/20/2002 | WO2002047713A2 Composition containing a mixture of growth factor for the treatment of renal injury |
| 06/20/2002 | WO2002047712A2 Peptide yy and peptide yy agonists for treatment of metabolic disorders |
| 06/20/2002 | WO2002047613A2 Immunogenic cancer peptides and uses thereof |
| 06/20/2002 | WO2002047534A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 06/20/2002 | WO2002047479A2 Cloning bovines by nuclear transplantation |
| 06/20/2002 | WO2002047478A2 Transgenic mice containing proliferator-activated receptor gene disruptions |
| 06/20/2002 | WO2002047477A2 Transgenic mice containing huntingtin interacting protein 1 gene disruptions |
| 06/20/2002 | WO2002047475A1 Method of efficiently constructing transgenic birds and transgenic birds thus obtained |
| 06/20/2002 | WO2002047474A1 Transgenic animal expressing hla-a24 and utilization thereof |
| 06/20/2002 | WO2002042475A8 Gene hd3a inducing flowering of plant and utilization thereof |
| 06/20/2002 | WO2002040518A8 Periplasmic domain of an enterobacterium omp protein and its use as carrier or adjuvant |
| 06/20/2002 | WO2002034894A3 Plant promoter providing high levels of gene expression in fruits |
| 06/20/2002 | WO2002027001A3 Plants with masked fertility |
| 06/20/2002 | WO2002026764A3 Haplotypes of the ccr6 gene |
| 06/20/2002 | WO2002022571A3 Compounds and methods for inhibiting alpha-1 beta-1 integrins |
| 06/20/2002 | WO2002022077A3 Compositions and methods for inhibition of hiv-1 infection |
| 06/20/2002 | WO2002018426A3 Rabbit hemorrhagic disease vaccine and antigens |
| 06/20/2002 | WO2002016573A3 Genetically modified, non-human mammal containing an additional inducible regulator gene |
| 06/20/2002 | WO2002014474A3 Method of treating alzheimer's disease with cell therapy |
| 06/20/2002 | WO2002012459A3 Method for improved production of cyanophycin and the secondary products thereof |
| 06/20/2002 | WO2002012334A3 Snake venom polypeptide zsnk1 |
| 06/20/2002 | WO2002007763A3 Helicobacter pylori with modified lipopolysaccharide biosynthesis |
| 06/20/2002 | WO2002007740A3 Snake toxin and use thereof as a pharmaceutical |
| 06/20/2002 | WO2002004600A3 Novel compounds |
| 06/20/2002 | WO2002003911A8 Prevention and treatment of alzheimer's disease |
| 06/20/2002 | WO2002002580A3 Haplotypes of the etfb gene |
| 06/20/2002 | WO2002000711A3 Ev-vegf nucleic acids and polypeptides and methods of use |
| 06/20/2002 | WO2002000709A3 Cerebellin homologous polypeptides and therapeutic uses thereof |
| 06/20/2002 | WO2002000232A3 Methods and compositions for developing spore display systems for medicinal and industrial applications |
| 06/20/2002 | WO2001095933A3 Immunization through oral administration of a vaccine with an edible product |
| 06/20/2002 | WO2001094613A3 Methods and compounds for influencing beta3 integrin-dependent intracellular processes |
| 06/20/2002 | WO2001094393A3 Synthetic spider silk proteins and the expression thereof in transgenic plants |
| 06/20/2002 | WO2001092504A3 Triacylglycerol lipases from arabidopsis thaliana |
| 06/20/2002 | WO2001090191A3 ANTIBODIES CAPABLE TO SELECTIVELY DETECT PRION PrPSc ISOFORMS |
| 06/20/2002 | WO2001090152A3 Compositions and methods for the therapy and diagnosis of breast cancer |
| 06/20/2002 | WO2001090139A3 A ligand for enhancing oral and cns delivery of biological agents |
| 06/20/2002 | WO2001089281A3 Tumor-associated antigen (b132), characterized by seq. id. no. 2 |
| 06/20/2002 | WO2001087977A3 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci |
| 06/20/2002 | WO2001085950A3 Genes of the 1-desoxy-d-xylulose biosynthesis path |
| 06/20/2002 | WO2001085942A3 Cytoskeleton-associated proteins |
| 06/20/2002 | WO2001085941A3 Myc targets |